Tay Therapeutics, focused on developing small molecules for oncology and severe inherited diseases, today announced that it has entered into an exclusive license agreement with VYNE Therapeutics Inc. (Nasdaq: VYNE),
NeuroSense Therapeutics Ltd. today announced positive preliminary results from a novel biomarker study conducted to evaluate the potential of NeuroSense’s combination platform therapy for the treatment of Parkinson’s disease (PD), the second most common neurodegenerative disorder.
Bryn Pharma, LLC announced today the addition of three new executives to its leadership team: Nurry Hong, Chief Strategy and Business Development Officer; Steve Killmeyer, Chief Financial Officer (CFO); and, Lisa Lucifero, VP, Head of Human Resources. Michael Kaseta, CFO of Liquidia Corporation (Nasdaq: LQKA), has also been appointed to Bryn’s Board of Directors.
Cyclo Therapeutics, Inc. today announced that it has closed a private placement of its securities with Rafael Holdings, Inc. (NYSE:RFL) (“Rafael”) for the purchase of 2,514,970 shares of common stock and warrants.
Apyx Medical Corporation today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (“FDA”) for the use of its APR Handpiece in procedures for coagulation of soft tissues following liposuction, the most popular plastic surgery procedure in the world.
RENUVION® RECEIVES FDA CLEARANCE FOR SPECIFIC USE AFTER LIPOSUCTION Read More »
GlycoEra AG announced today that Santiago Arroyo , MD has been appointed to its Board of Directors.
Sphere Fluidics, a company developing single cell analysis systems underpinned by its patented picodroplet technology, announced that it has appointed Kenneth Hitchner, BA MBA, as Chairman of its Board of Directors.
Sphere Fluidics appoints Kenneth Hitchner as Chairman of its Board of Directors Read More »
Ascletis Pharma Inc. announces that ASC40, a first-in-class, once-daily oral fatty acid synthase inhibitor, achieved primary and key secondary endpoints in Phase II clinical trial for acne vulgaris.
¿El calentamiento global está cambiando la duración de las estaciones, climáticamente hablando? Desde un punto de vista meramente climático, los días de verano han pasado de 90 a 145, en los últimos 50 años, en las principales ciudades …
En este Short examinamos las razones por las cuales podemos llegar a sentir dolor de cabeza. …
